Hemodynamic Effects of Bosentan in Patients with Chronic Heart Failure
Authors:
- 1 December 2001
- journal article
- research article
- Published by Springer Nature in Heart Failure Reviews
- Vol. 6 (4) , 325-334
Abstract
A role of the potent and long-acting vasoconstrictor peptide endothelin-1 and the pathophysiology of chronic human heart failure has been postulated based upon indirect evidence such as elevated...Keywords
This publication has 51 references indexed in Scilit:
- Acute hemodynamic and neurohumoral effects of selective ETA receptor blockade in patients with congestive heart failureJACC, 2000
- Receptor- and non-receptor-mediated clearance of bigendothelin and endothelin-1Journal Of Hypertension, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Impact of Medical Therapy on Pulmonary Hypertension in Patients With Congestive Heart Failure Awaiting Cardiac TransplantationThe American Journal of Cardiology, 1996
- ETB-Mediated Regulation of Extracellular Levels of Endothelin-1 in Cultured Human Endothelial CellsBiochemical and Biophysical Research Communications, 1995
- Endothelin-1 stimulation of aldosterone and zona glomerulosa ouabain-sensitive sodium/potassium-ATPaseThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- Clearance of Circulating Endothelin-1 by ETB Receptors in RatsBiochemical and Biophysical Research Communications, 1994
- Cloning and characterization of cDNA encoding human a-type endothelin receptorBiochemical and Biophysical Research Communications, 1991
- Cloning and sequence analysis of a cDNA encoding human non-selective type of endothelin receptorBiochemical and Biophysical Research Communications, 1991
- Presence of non‐selective type of endothelin receptor on vascular endothelium and its linkage to vasodilationFEBS Letters, 1991